Genetic Testing Could Greatly Benefit Patients with Depression
A special kind of genetic testing that determines the best antidepressant for patients with depression may greatly improve patient outcomes.
Read MorePosted by Andy Lundin | Nov 14, 2023 | Molecular Diagnostics |
A special kind of genetic testing that determines the best antidepressant for patients with depression may greatly improve patient outcomes.
Read MorePosted by Andy Lundin | Nov 7, 2023 | Company News, Molecular Diagnostics |
Veracyte and Illumina will develop high-performing molecular tests as decentralized IVD tests on Illumina’s NextSeq 550Dx NGS instrument.
Read MorePosted by Andy Lundin | Nov 3, 2023 | Covid 19, Diagnostic Technologies, Swabs |
The prototype device uses lab-on-a-chip technology and has been proven to provide rapid and low-cost detection of COVID from nasal swabs.
Read MorePosted by Andy Lundin | Nov 2, 2023 | Cervical (HPV), Molecular Diagnostics |
Abbott received FDA approval for its molecular HPV screening solution for its Alinity m family of diagnostic assays.
Read MorePosted by Andy Lundin | Nov 2, 2023 | Information Technology |
Genomenon says it is delivering a catalog of more than 9,000 gene-disease relationships across 5,500 genes, with more being added each week.
Read More